Talaporfin
| Clinical data | |
|---|---|
| AHFS/Drugs.com | International Drug Names | 
| Routes of administration | IV | 
| ATC code | 
 | 
| Legal status | |
| Legal status | 
 | 
| Identifiers | |
| 
 | |
| CAS Number | 
 | 
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C38H41N5O9 | 
| Molar mass | 711.772 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
| (what is this?) (verify) | |
Talaporfin (INN, also known as aspartyl chlorin, mono-L-aspartyl chlorin e6, NPe6, or LS11) is a chlorin based photosensitizer used in photodynamic therapy (PDT).
It absorbs red light at 664-667 nm normally provided by a laser tuned to this wavelength.
It was approved in Japan (in 2004) for PDT of lung cancer and marketed as Laserphyrin.